In vitro diagnostic test systems — Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens — Laboratory quality practice guide
Introduction: Nucleic acid amplification-based tests (NAATs) are now commonly used in in vitro diagnostic (IVD) tools in laboratory medicine for the detection, identification and quantification of microbial pathogens. The NAAT result is influenced by all steps of the entire diagnostic workflow (i.e. pre-examination, examination, post-examination). Therefore, this document considers all critical aspects of the entire diagnostic workflow when designing, developing and implementing and using a specific microbial pathogen NAAT examination. NAAT examinations include PCR technology as well as other amplification-based technologies such as, but not limited to, loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA) and strand displacement amplification (SDA). This document covers the implementation of commercially available IVD(s) into the medical laboratory routine use as well as the design, development and implementation of laboratory developed tests (LDT). This document will address the additional specific considerations, requirements and recommendations for the detection of microbial pathogens with sampling, nucleic acid extraction, genetic heterogeneity and the laboratory containment category which is required. Due to high analytical sensitivity of nucleic acid-based examination procedures, special attention to their design, development and use is required. This includes verification of analytical and validation of clinical performance characteristics. In th
Scope: This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT). It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.